Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The future of inhalation therapy in chronic obstructive pulmonary disease
Mario Cazzola, Josuel Ora, Luigino Calzetta, et al.
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100092-100092
Open Access | Times Cited: 16

Showing 16 citing articles:

Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: Challenges, recent advances, and future perspectives
Vijay Kumar Panthi, Kathryn E. Fairfull‐Smith, Nazrul Islam
Journal of Drug Delivery Science and Technology (2024) Vol. 94, pp. 105517-105517
Open Access | Times Cited: 6
Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System
Felisbela Gomes, Shih-Lung Cheng
Biomolecules (2023) Vol. 13, Iss. 3, pp. 476-476
Open Access | Times Cited: 12
Recent advances predict a bright future for nebulizers
Michael Troy, Joseph Van Vleet, Donald P. Tashkin, et al.
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 2, pp. 123-132
Closed Access | Times Cited: 8
The effects of temperature and humidity on the deposition of nebulized droplet in an idealized mouth-throat model
Huizhen Yang, Yan Wang, Xiaole Chen, et al.
Flow Measurement and Instrumentation (2023) Vol. 91, pp. 102359-102359
Closed Access | Times Cited: 8
Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval
Luigino Calzetta, Elena Pistocchini, Alfredo Chetta, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 6, pp. 525-536
Closed Access | Times Cited: 7
Discovery and Characterization of a Bicyclic Peptide (Bicycle) Binder to Thymic Stromal Lymphopoietin
Frank Narjes, Fredrik Edfeldt, Jens Petersen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 2220-2235
Closed Access | Times Cited: 2
The need for inhaled phosphodiesterase inhibitors in chronic obstructive pulmonary disease
Mario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
Expert Review of Clinical Pharmacology (2024)
Closed Access | Times Cited: 2
A novel experimental approach to measure nebulized droplet deposition pattern and deposition fraction in an idealized mouth-to-throat model
Yi Jin, Xiaole Chen, Yu Feng, et al.
Physics of Fluids (2023) Vol. 35, Iss. 8
Open Access | Times Cited: 6
Involvement of GPR43 Receptor in Effect of Lacticaseibacillus rhamnosus on Murine Steroid Resistant Chronic Obstructive Pulmonary Disease: Relevance to Pro-Inflammatory Mediators and Oxidative Stress in Human Macrophages
Ana Karolina Sá, Fabiana Regina da Silva Olímpio, J. Vasconcelos, et al.
Nutrients (2024) Vol. 16, Iss. 10, pp. 1509-1509
Open Access | Times Cited: 1
Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
Laura Carzaniga, Ian D. Linney, A. Rizzi, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 9816-9841
Closed Access | Times Cited: 1
Recalibrating Perceptions and Attitudes Toward Nebulizers versus Inhalers for Maintenance Therapy in COPD: Past as Prologue
Rajiv Dhand, Michael W Hess, Abebaw Mengistu Yohannes
International Journal of COPD (2024) Vol. Volume 19, pp. 2571-2586
Open Access | Times Cited: 1
Droplet deposition dynamics in a realistic three-dimensionally printed human upper airway: An in vitro study
Jiayi Huang, Ya Zhang, Xiaole Chen, et al.
Physics of Fluids (2024) Vol. 36, Iss. 12
Closed Access | Times Cited: 1
Lung Deposition of Air Pollutants and Inhaled Drugs in Patients with Chronic Obstructive Pulmonary Disease (COPD) and those on Non-Invasive Ventilation (NIV): Is It Still Challenging?
Radmila Dmitrović, Isidora Simonović
IntechOpen eBooks (2024)
Open Access
Real-World Treatment Patterns and Patient-Reported Outcomes in Chronic Obstructive Pulmonary Disease in Japan: The REMIND Study
Yasuhiro Gon, Ryoko Sorimachi, Yuri Yoshida, et al.
Advances in Therapy (2024) Vol. 41, Iss. 9, pp. 3585-3597
Open Access
A clinician’s guide to single vs multiple inhaler therapy for COPD
Mario Cazzola, Josuel Ora, Mauro Maniscalco, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 7, pp. 457-468
Closed Access
Perceptions of the effectiveness of non-pharmacological management of respiratory disorders among CRD patients
Yousef S Aldabayan
Medicine (2023) Vol. 102, Iss. 41, pp. e35474-e35474
Open Access
Page 1

Scroll to top